127 related articles for article (PubMed ID: 12670648)
1. A quantitative structure-activity relationship study of hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.
Gupta SP; Kumar D; Kumaran S
Bioorg Med Chem; 2003 May; 11(9):1975-81. PubMed ID: 12670648
[TBL] [Abstract][Full Text] [Related]
2. A comparative QSAR study on carbonic anhydrase and matrix metalloproteinase inhibition by sulfonylated amino acid hydroxamates.
Gupta SP; Maheswaran V; Pande V; Kumar D
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):7-13. PubMed ID: 12751815
[TBL] [Abstract][Full Text] [Related]
3. A quantitative structure-activity relationship study on some matrix metalloproteinase and collagenase inhibitors.
Kumar D; Gupta SP
Bioorg Med Chem; 2003 Feb; 11(3):421-6. PubMed ID: 12517437
[TBL] [Abstract][Full Text] [Related]
4. Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.
Natchus MG; Bookland RG; De B; Almstead NG; Pikul S; Janusz MJ; Heitmeyer SA; Hookfin EB; Hsieh LC; Dowty ME; Dietsch CR; Patel VS; Garver SM; Gu F; Pokross ME; Mieling GE; Baker TR; Foltz DJ; Peng SX; Bornes DM; Strojnowski MJ; Taiwo YO
J Med Chem; 2000 Dec; 43(26):4948-63. PubMed ID: 11150165
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.
Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ
Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623
[TBL] [Abstract][Full Text] [Related]
6. QSAR analysis of some 5-amino-2-mercapto-1,3,4-thiadiazole based inhibitors of matrix metalloproteinases and bacterial collagenase.
Jamloki A; Karthikeyan C; Hari Narayana Moorthy NS; Trivedi P
Bioorg Med Chem Lett; 2006 Jul; 16(14):3847-54. PubMed ID: 16682189
[TBL] [Abstract][Full Text] [Related]
7. Tetrahydroisoquinoline based sulfonamide hydroxamates as potent matrix metalloproteinase inhibitors.
Ma D; Wu W; Yang G; Li J; Li J; Ye Q
Bioorg Med Chem Lett; 2004 Jan; 14(1):47-50. PubMed ID: 14684295
[TBL] [Abstract][Full Text] [Related]
8. alpha-Amino-beta-sulphone hydroxamates as potent MMP-13 inhibitors that spare MMP-1.
Becker DP; Barta TE; Bedell L; DeCrescenzo G; Freskos J; Getman DP; Hockerman SL; Li M; Mehta P; Mischke B; Munie GE; Swearingen C; Villamil CI
Bioorg Med Chem Lett; 2001 Oct; 11(20):2719-22. PubMed ID: 11591509
[TBL] [Abstract][Full Text] [Related]
9. A quantitative structure-activity relationship study on matrix metalloproteinase inhibitors: piperidine sulfonamide aryl hydroxamic acid analogs.
Kumaran S; Gupta SP
J Enzyme Inhib Med Chem; 2007 Feb; 22(1):23-7. PubMed ID: 17373543
[TBL] [Abstract][Full Text] [Related]
10. alpha-Alkyl-alpha-amino-beta-sulphone hydroxamates as potent MMP inhibitors that spare MMP-1.
Becker DP; DeCrescenzo G; Freskos J; Getman DP; Hockerman SL; Li M; Mehta P; Munie GE; Swearingen C
Bioorg Med Chem Lett; 2001 Oct; 11(20):2723-5. PubMed ID: 11591510
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
Scozzafava A; Supuran CT
J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
[TBL] [Abstract][Full Text] [Related]
12. A quantitative structure-activity relationship study on Clostridium histolyticum collagenase inhibitors: roles of electrotopological state indices.
Gupta SP; Kumaran S
Bioorg Med Chem; 2003 Jul; 11(14):3065-71. PubMed ID: 12818668
[TBL] [Abstract][Full Text] [Related]
13. A quantitative structure-activity relationship study on some novel series of hydroxamic acid analogs acting as matrix metalloproteinase inhibitors.
Kumaran S; Gupta SP
Med Chem; 2007 Mar; 3(2):167-73. PubMed ID: 17348854
[TBL] [Abstract][Full Text] [Related]
14. QSAR of matrix metalloproteinase inhibitor N-[(substituted phenyl)sulfonyl]-N-4-nitrobenzylglycine hydroxamates using LFER model.
Roy K; Pal DK; De AU; Sengupta C
Drug Des Discov; 2001; 17(4):315-23. PubMed ID: 11765134
[TBL] [Abstract][Full Text] [Related]
15. Quantitative structure-activity relationship studies on matrix metalloproteinase inhibitors: hydroxamic acid analogs.
Gupta SP; Kumaran S
Med Chem; 2006 May; 2(3):243-50. PubMed ID: 16948470
[TBL] [Abstract][Full Text] [Related]
16. MMP-2 selectivity in hydroxamate-type inhibitors.
Serra P; Bruczko M; Zapico JM; Puckowska A; Garcia MA; Martin-Santamaria S; Ramos A; de Pascual-Teresa B
Curr Med Chem; 2012; 19(7):1036-64. PubMed ID: 22257051
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.
Hanessian S; MacKay DB; Moitessier N
J Med Chem; 2001 Sep; 44(19):3074-82. PubMed ID: 11543676
[TBL] [Abstract][Full Text] [Related]
18. Novel bis-(arylsulfonamide) hydroxamate-based selective MMP inhibitors.
Subramaniam R; Haldar MK; Tobwala S; Ganguly B; Srivastava DK; Mallik S
Bioorg Med Chem Lett; 2008 Jun; 18(11):3333-7. PubMed ID: 18442906
[TBL] [Abstract][Full Text] [Related]
19. A quantitative structure-activity relationship study on some series of anthranilic acid-based matrix metalloproteinase inhibitors.
Gupta SP; Kumaran S
Bioorg Med Chem; 2005 Sep; 13(18):5454-62. PubMed ID: 15993609
[TBL] [Abstract][Full Text] [Related]
20. MMP-13 selective α-sulfone hydroxamates: a survey of P1' heterocyclic amide isosteres.
Barta TE; Becker DP; Bedell LJ; Easton AM; Hockerman SL; Kiefer J; Munie GE; Mathis KJ; Li MH; Rico JG; Villamil CI; Williams JM
Bioorg Med Chem Lett; 2011 May; 21(10):2820-2. PubMed ID: 21507637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
